JAK Inhibitor Prior to Allogeneic Stem Cell Transplant for Patients With Primary and Secondary Myelofibrosis: A Prospective Study
Phase of Trial: Phase II
Latest Information Update: 27 May 2017
At a glance
- Drugs Momelotinib (Primary) ; Pacritinib (Primary) ; Ruxolitinib (Primary) ; Busulfan; Cyclophosphamide; Fludarabine; Melphalan; Methotrexate; Mycophenolate mofetil; Mycophenolate mofetil; Tacrolimus; Tacrolimus
- Indications Myelofibrosis
- Focus Therapeutic Use
- 22 May 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2018.
- 04 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 13 Oct 2014 New trial record